InMed Pharmaceuticals Inc.
Close on Oct 19, 2026
- Market cap
- $6.42M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q1 FY2021 Ended Sep 30, 2020 | Nov 13, 2020 | During market hours | – | – | – |
Press releases
Announcements InMed Pharmaceuticals filed with the SEC
c/o Norton Rose Fulbright Canada LLP
Listing notice · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED ON JULY 22, 2026
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED ON JULY 6, 2026
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Suite 1445-885 West Georgia St.
Other events · EX-99.1 to Form 8-K
PRESS RELEASE, ISSUED ON MAY 19, 2026
Material agreement · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
INVESTOR PRESENTATION, DATED MAY 2026
Material agreement · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
CONFERENCE CALL TRANSCRIPT DATED MAY 19, 2026
Material agreement · Executive or director change · Regulation FD disclosure · EX-99.3 to Form 8-K
Suite 1445-885 West Georgia St.
Material agreement · Other events · EX-99.1 to Form 8-K
Suite 1445-885 West Georgia St.
Regulation FD disclosure · EX-99.1 to Form 8-K
Suite 1445-885 West Georgia St.
Material agreement · Other events · EX-99.1 to Form 8-K
1445 - 885 West Georgia St.
Regulation FD disclosure · EX-99.1 to Form 8-K
1445 - 885 West Georgia St.
Regulation FD disclosure · EX-99.1 to Form 8-K
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION OF INMED PHARMACEUTICALS INC
Exit or restructuring costs · Regulation FD disclosure · EX-99.1 to Form 8-K
1445 – 885 West Georgia St.
Exit or restructuring costs · Regulation FD disclosure · EX-99.2 to Form 8-K
1445 - 885 West Georgia St.
Regulation FD disclosure · EX-99.1 to Form 8-K
1445 - 885 West Georgia St.
Shareholder vote results · Regulation FD disclosure · EX-99.1 to Form 8-K
NEWS RELEASE, DATED DECEMBER 12, 2025
Other events · EX-99.1 to Form 8-K
NEWS RELEASE, DATED NOVEMBER 18, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE FILED OCTOBER 16, 2025
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
SEDAR FILING SUBMITTED OCTOBER 10, 2025
Other events · EX-99.1 to Form 8-K
PRESS RELEASE FILED OCTOBER 9, 2025
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
NEWS RELEASE, DATED SEPTEMBER 23, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
SEDAR FILING SUBMITTED SEPTEMBER 23, 2025
Other events · EX-99.1 to Form 8-K
NEWS RELEASE, DATED SEPTEMBER 5, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
NEWS RELEASE, DATED JULY 28, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED JUNE 25, 2025
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED JUNE 26, 2025
Material agreement · Unregistered share sale · Other events · EX-99.2 to Form 8-K
NEWS RELEASE, DATED JUNE 24, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
NEWS RELEASE, DATED MAY 12, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
AMENDED NOTICE OF MEETING AND RECORD DATE
Other events · EX-99.1 to Form 8-K
SEDAR FILING SUBMITTED APRIL 4, 2025
Other events · EX-99.1 to Form 8-K
RESIGNATION LETTER OF JANET GROVE
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, DATED FEBRUARY 12, 2025
Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
NEWS RELEASE, DATED FEBRUARY 12, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
NEWS RELEASE, DATED FEBRUARY 3, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
NEWS RELEASE, DATED JANUARY 22, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
NEWS RELEASE, DATED JANUARY 21, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, DATED DECEMBER 18, 2024
Shareholder vote results · Regulation FD disclosure · EX-99.1 to Form 8-K
NEWS RELEASE, DATED DECEMBER 17, 2024
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
NEWS RELEASE, DATED NOVEMBER 19, 2024
Regulation FD disclosure · EX-99.1 to Form 8-K